EyeControl

Wearable Assistive Communication Device

Startup

EyeControl is a Bnei Brak-based startup in the Health Tech & Life Sciences sector, established in 2016. Wearable Assistive Communication Device. The company has raised a total of $15.21M across 13 funding rounds, currently at the A stage. EyeControl was founded by Or Retzkin and Itai Kornberg. Key investors include European Innovation Council, Connecticut Innovations, Clive Barret, among 13 total investors. The company has 11-50 employees. Core technologies: Platforms & Interfaces, Software, Mobile, Semiconductors & Electronics, Wearables, Artificial Intelligence, Machine Learning, Computer Vision, Communications.

With $15.21M in total funding, EyeControl is a A-stage company operating in Health Tech & Life Sciences. The company follows a B2C/B2B/B2B2C business model. Product stage: Released. The company holds 1 patent.

$15.21M
Raised
13
Rounds
13
Investors
3
Team
2016
Founded
1
Patents
Sector & Technology
Health Tech & Life SciencesMedical DevicesAssistive DevicesDigital HealthcareDigital Accessibility SolutionsPlatforms & InterfacesSoftwareMobileSemiconductors & ElectronicsWearablesArtificial IntelligenceMachine LearningComputer VisionCommunications
At a Glance
Investors

13 investors total

Founders
In the News

10 articles covered by sources including www.jpost.com, www.haaretz.com, www.themarker.com, www.timesofisrael.com, techtime.co.il.

www.jpost.com · Jun 30, 2024
Israeli company EyeControl creates revolutionary medical technology
Read article ↗
Frequently Asked Questions
What does EyeControl do?

EyeControl is a medical technology company revolutionizing ICU care with its AI-powered eye-tracking platform. Designed to empower mechanically ventilated patients, it enables effective communication, connects families and caregivers, and provides healthcare teams with actionable insights. By supporting implementation of evidence-based practices for optimizing critical care, EyeControl enhances patient safety, improves cognitive and mental health outcomes, and fosters meaningful connections. The EyeControl device is FDA-listed, CE-marked, ISO-certified, and AMAR and MAKAT registered as a communication solution. It is federally reimbursed in Israel for inpatient settings and homecare.

How much funding has EyeControl raised?

EyeControl has raised $15.21M in total funding across 13 rounds. The company is currently at the A stage. Key investors include European Innovation Council, Connecticut Innovations, Clive Barret.

Who founded EyeControl?

EyeControl was founded in 2016 by Or Retzkin (Co-founder & CEO), Itai Kornberg (Co-founder & CTO).

What sector is EyeControl in?

EyeControl operates in Health Tech & Life Sciences, Medical Devices, Assistive Devices, Digital Healthcare, Digital Accessibility Solutions, with core technologies in Platforms & Interfaces, Software, Mobile, Semiconductors & Electronics, Wearables, Artificial Intelligence, Machine Learning, Computer Vision, Communications. Target customers: Healthcare & Life Sciences, Healthcare, Patients, Providers.

Where is EyeControl located?

EyeControl is based in Menachem Begin Street 48, Tel Aviv, Israel, Center District.

View Full Profile Classic View Website ↗